Teva, Allergan Finalize Multibillion-Dollar Global Opioid Deals
Teva on Tuesday said that it had finalized a global deal worth up to $4.25 billion to end allegations brought by states and local governments that it fueled the opioid crisis...To view the full article, register now.
Already a subscriber? Click here to view full article